倍(bei)(bei)特(te)(te)藥(yao)(yao)(yao)業(ye)集(ji)團(tuan)(tuan)成(cheng)(cheng)立于2007年(nian)(nian)，是一家(jia)(jia)集(ji)藥(yao)(yao)(yao)品(pin)研(yan)(yan)(yan)(yan)發(fa)(fa)(fa)、生(sheng)(sheng)產(chan)和(he)(he)銷售于一體的(de)高(gao)新(xin)技術企(qi)(qi)業(ye)，國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)醫藥(yao)(yao)(yao)工(gong)業(ye)百(bai)強企(qi)(qi)業(ye)之一，2003年(nian)(nian)建(jian)成(cheng)(cheng)“成(cheng)(cheng)都(dou)高(gao)新(xin)區企(qi)(qi)業(ye)博(bo)士(shi)后科(ke)研(yan)(yan)(yan)(yan)工(gong)作(zuo)站”，2011年(nian)(nian)，被評(ping)為四(si)川省(sheng)、成(cheng)(cheng)都(dou)市“企(qi)(qi)業(ye)技術中(zhong)心”、“國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)級高(gao)新(xin)技術企(qi)(qi)業(ye)”，是國(guo)(guo)(guo)(guo)(guo)內知名(ming)(ming)制(zhi)(zhi)藥(yao)(yao)(yao)企(qi)(qi)業(ye)之一，2013年(nian)(nian)被列(lie)為全(quan)(quan)國(guo)(guo)(guo)(guo)(guo)藥(yao)(yao)(yao)企(qi)(qi)新(xin)藥(yao)(yao)(yao)注冊申(shen)報TOP100名(ming)(ming)單，名(ming)(ming)列(lie)西南地(di)(di)(di)(di)區申(shen)報數(shu)量前(qian)列(lie)。主要(yao)品(pin)種(zhong)涵蓋：抗消(xiao)炎、心血管、婦科(ke)、神經(jing)、泌尿、消(xiao)化等領域。 經(jing)過多年(nian)(nian)的(de)跨越(yue)式發(fa)(fa)(fa)展(zhan)(zhan)，旗下擁有(you)多家(jia)(jia)子公司，其(qi)中(zhong)兩個原(yuan)料藥(yao)(yao)(yao)品(pin)生(sheng)(sheng)產(chan)基(ji)(ji)(ji)地(di)(di)(di)(di)，三個制(zhi)(zhi)劑生(sheng)(sheng)產(chan)基(ji)(ji)(ji)地(di)(di)(di)(di)，所有(you)基(ji)(ji)(ji)地(di)(di)(di)(di)全(quan)(quan)部通過國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)GMP認(ren)證，其(qi)中(zhong)普銳(rui)特(te)(te)生(sheng)(sheng)產(chan)基(ji)(ji)(ji)地(di)(di)(di)(di)以(yi)高(gao)標準進(jin)行規劃(hua)，計劃(hua)2017年(nian)(nian)通過歐盟和(he)(he)FDA認(ren)證，倍(bei)(bei)特(te)(te)科(ke)研(yan)(yan)(yan)(yan)中(zhong)心由倍(bei)(bei)特(te)(te)藥(yao)(yao)(yao)物研(yan)(yan)(yan)(yan)究院、普銳(rui)特(te)(te)藥(yao)(yao)(yao)物研(yan)(yan)(yan)(yan)究院、紐銳(rui)特(te)(te)核藥(yao)(yao)(yao)研(yan)(yan)(yan)(yan)究院、南京新(xin)藥(yao)(yao)(yao)研(yan)(yan)(yan)(yan)究院四(si)家(jia)(jia)機(ji)構組成(cheng)(cheng)，集(ji)團(tuan)(tuan)每年(nian)(nian)投(tou)入上(shang)億(yi)元，用于新(xin)藥(yao)(yao)(yao)的(de)研(yan)(yan)(yan)(yan)發(fa)(fa)(fa)。科(ke)研(yan)(yan)(yan)(yan)中(zhong)心擁有(you)國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)“千人計劃(hua)”、四(si)川省(sheng)“百(bai)人計劃(hua)”、世(shi)界一流新(xin)藥(yao)(yao)(yao)研(yan)(yan)(yan)(yan)發(fa)(fa)(fa)專家(jia)(jia)多名(ming)(ming)。目(mu)(mu)(mu)前(qian)待(dai)國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)局審批的(de)三類以(yi)上(shang)新(xin)藥(yao)(yao)(yao)達八十(shi)多個品(pin)種(zhong)，擁有(you)多個國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)定點生(sheng)(sheng)產(chan)品(pin)種(zhong)和(he)(he)獨家(jia)(jia)生(sheng)(sheng)產(chan)品(pin)種(zhong)，目(mu)(mu)(mu)前(qian)已逐(zhu)步形(xing)成(cheng)(cheng)研(yan)(yan)(yan)(yan)發(fa)(fa)(fa)能力領先、劑型(xing)和(he)(he)品(pin)種(zhong)完善(shan)、營(ying)銷網絡健全(quan)(quan)的(de)大型(xing)醫藥(yao)(yao)(yao)企(qi)(qi)業(ye)。集(ji)團(tuan)(tuan)已完成(cheng)(cheng)了既(ji)定的(de)十(shi)年(nian)(nian)發(fa)(fa)(fa)展(zhan)(zhan)目(mu)(mu)(mu)標，目(mu)(mu)(mu)前(qian)緊隨國(guo)(guo)(guo)(guo)(guo)家(jia)(jia)十(shi)三五(wu)(wu)規劃(hua)制(zhi)(zhi)定企(qi)(qi)業(ye)的(de)下一個五(wu)(wu)年(nian)(nian)發(fa)(fa)(fa)展(zhan)(zhan)規劃(hua)。